The Latest in Non-Hodgkin Lymphoma

EC authorizes new use for ofatumumab in CLL

December 14, 2016

EC grants venetoclax conditional approval for CLL

December 9, 2016

Drug produces responses in ‘challenging’ patients

December 9, 2016

Data suggest one BTK inhibitor could replace another

December 8, 2016

Group estimates global cancer cases, deaths in 2015

December 8, 2016

Obinutuzumab bests rituximab in FL study

December 6, 2016

NICE recommends taking ibrutinib off CDF

November 30, 2016

Tazemetostat receives fast track designation for DLBCL

November 29, 2016

Novel CLL drugs could greatly increase costs

November 22, 2016

How EBV drives lymphomagenesis

November 14, 2016

Drug dubbed ‘breakthrough’ for CTCL subtypes

November 12, 2016

CHMP recommends expanding use of drug in CLL

November 11, 2016

Blood test can predict outcomes in DLBCL, team says

November 10, 2016

Combine flow and HTS for sensitive MRD detection in CLL, speaker says

November 4, 2016

NORD publishes physician guide to CTCL

October 28, 2016